Lv1
50 积分 2022-05-12 加入
Design and Development of DNA Damage Chemical Inducers of Proximity for Targeted Cancer Therapy
2个月前
已完结
Abstract 4580: Novel PCNA inhibitor AOH1996 synergizes with KRAS-targeted therapies in pancreatic ductal adenocarcinoma
2个月前
已完结
JYP0322, a highly selective and brain-penetrant ROS1 inhibitor, overcomes ROS1 resistance mutation in NSCLC: The first-in-human phase 1 trial
2个月前
已关闭
Abstract 5791: Preclinical characterization of NEO-811, a novel molecular glue degrader of ARNT for the treatment of clear cell renal cell carcinoma
2个月前
已关闭
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
2个月前
已完结
Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
2个月前
已完结
A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance
5个月前
已完结
Development of a Cost-Efficient Process Toward a Key Synthetic Intermediate of the EZH2 Inhibitor PF-06821497
9个月前
已完结
A Modified Arbuzov‐Michalis Reaction for Selective Alkylation of Nucleophiles
10个月前
已完结
皖公网安备34019202002308
